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CHRONIC STIMULATION OF THE 
HYPOTHALAMUS-PITUITARY-ADRENAL AXIS 
IN RATS BY INTERLEUKIN lß: CENTRAL AND 
PERIPHERAL MECHANISMS
Mike J. M. van der Meer,1 C. G. J. (Fred) Sweep,2 Gerard J. Pesman,2
Fred J. H. Tilders,3 Ad R. M. M. Hermus1
The authors have studied mechanisms which could be involved in the sustained activation of the 
hypothalamus-pituitary-adrenal (HPA) axis during continuous infusion of rats with 
recombinant human interleukin-1 ß (IL-lß). First, the effects of 3 days of intracerebroventricular 
(i.c.v.) infusion of rats with IL-1 on plasma adrenocorticotropin (ACTH) and corticosterone (B) 
levels were investigated. Thereafter, changes in plasma ACTH and B levels were followed in rats 
intraperitoneally (i.p.) infused with IL-lß after iinmunoneutralization of corticotropin-releasing 
hormone (CRH), hypophyseetomy (HPX), macrophage depletion using dichlorometliylene 
diphosphonate (Cl2 MDP)-containing liposomes, adrenalectomy (ADX) and dexamethasone 
(DEX) administration, respectively. Infusion of IL-lß i.c.v., even in doses as low as 0.1 pg/day, 
induced significant increases in plasma ACTH and B levels. HPX and ADX rats died within 
18 h after starting the IL-lß infusion (0.5 jxg/day). Iinmunoneutralization of CRH significantly 
decreased and macrophage depletion significantly increased the stimulation of the HPA axis by 
IL-1 (4.0 pg/day). Administration of high doses of DEX completely abolished the stimulation
I P
lß  (2.0 (xg/day)
lß
evidence that the CRH system is involved; (2) provides no evidence for a direct stimulatory effect 
of IL-lß on the release of B by the adrenal gland which is of sufficient magnitude to resist the
l ß
Iß
the activity of the HPA axis; (4) demonstrates that exogenous administration of DEX blocks 
the effect of IL-lß, which fits well in the concept of an immunoregulatory feedback between 
IL-lß and glucocorticoids.
( 14) %  A c a d e m i c  P r e s s  U m i f e r i
■
There is increasing evidence that bidirectional com- by macrophages, is thought to be a mediator of this
m unication 111e i m m u ne a n d
neuroendocrine system enables an organism to respond 
appropriately to disturbances of its homeostasis by
and inflammation.1,2 During circum­
stances activation of the hypothalamus pituitary 
adrenal axis (HPA axis) is of utmost importance and 
interleukin-lß (IL-lß), a polypeptide mainly produced
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activation. i s of IL-lß have
measured in biological fluids of patients suffering from
some s or inflammatory , most
probably indicating chronically elevated IL-lß pro­
duction during these circumstances. In this context we 
have previously shown that continuous intraperitoneal 
(i.p.) infusion of rats with IL-lß (2 and 4 fig/day) for 
7 days induced sustained activation of the HPA axis, 
an increase in rectal temperature and a decrease in food 
intake/’
In the present study wc have extended our ear 
observations on chronic IL-lß infusion in rats and we
some potential mechanisms which 
could be involved in the activation of the HPA axis 
during 3 days of continuous infusion with IL-lß. First,
authors investigated whether, like chronic i.p.
IL-lß, chronic central infusion of 
IL-lß is also able to activate the HPA axis. Therefore, 
IL-lß was infused for 3 days into the cerebroventrieu-
have i
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Chronic 11 - 1 inl'usion und mechanisms of UFA axis activation M)U
lar system in
\  L 1 ^
than  in our i.p. infusion 
we investigated the involvement o f  the 
corticotropin-releasing horm one (C R H ) system in the 
activation of the H PA  axis during continuous i.p. 
infusion by IL - lß  by pretreatm ent o f the rats with a
m onoclonal an ti-C R H  antibody. Third, 
peripheral mechanisms, such as release of mediators 
from IL-1 ß-activated m acrophages or a direct effect of 
IL - lß  on corticosterone (B) production  by the adrenal 
glands, are involved in the activation o f the HPA axis
•mg continuous i.p. infusion ol IL -lß  was investi­
gated. Therefore, IL - lß  was chronically infused i.p. in 
m acrophage-depleted rats and  in hypophyseetomized 
rats. Finally, whether high o r  low concentrations of 
circulating glucocorticoids are capable o f  modulating 
the effects o f continuously infused IL - lß  was examined. 
For this purpose IL - lß  was infused i.p. in rats treated
s o f  the synthetic glucocorticoid 
dexam ethasone and in adrenalectomized rats. Plasma 
A C TH  and B levels were m easured in b lood samples 
which were w ithdraw n daily by means o f  a chronic 
jugular cannula . In addition, we examined in all 
experiments the effects o f  the different (pre)treatments 
o f rats on rectal tem perature, body weight change, and 
on food and fluid intake.
R E S U L T S
Infusion peripheral and central) of IL -lß  
o f  physical to
animals, including piloerection and decreased physical 
activity, s tarting  a few hours after im plantation o f  the 
pumps. This visually 
diminished during 
disappeared on day 2.
li neasi ness grad ually 
first day o f  infusion and
Effects o f  intracerebroventricular infusion o f rats
with IL- lß
Figure 1 shows the effects o f 3 days continuous 
i.c.v. infusion of saline or IL - lß  (100 and 500 ng
1L - 1 ay) on plasma levels of A C T H  and ree t a I
tem perature, daily body weight change and  on food 
a n d 
I L - 1
intake. C ontinuous infusion o f 500 ng 
ay induced a significant increase in plasma 
A CTH levels. Due to shortage o f plasm a, A C TH  levels 
o f  animals infused with 100 ng IL -lß /d ay  could not be
measured. In tracerebroventricular infusion of IL -lß
increase (P < 0.0005) ina
plasma B levels (A U C ) and a dose-dependent increase
(saline: 44.8 +
ng IL-
(P <  0.0005) in total adrenal 
0.7 mg; 100 ng IL-lß: 46.7 ± 1 .3  mg;
57.3 ±  2.2 mg; m ean ±  SEM ol 10 11 rats). D unnetl 's  
/-test revealed that the adrenal weight o f  rats infused 
with the highest dose o f IL - lß  was significantly higher 
than that o f  saline-infused rats IP < 0.05). Rectal
t e m p e r a tu r e  increased dose-dependent ly (P < 0.0005) 
in r e s p o n s e  to chronic i.c.v. infusion o f IL -lß  (AUC).
Continuous i.c.v. infusion of IL -lß  induced a 
dose-dependent decrease in body weight gain and also 
in food  an d  fluid intake (AUC; all three: P <  0.0005).
Effects o f  pretreatment with anti-CRH 
in ra ts  infused i.p, with IL-iß or saline
•uni
F l ic  effects o f pretreatment of rats with anti-CRH
a n t i s e r u n i  on : ear id parameters in rats
in fuse ti  i.p. with IL -lß  (4.0 (..ig/day) or saline are shown 
in F i g u r e  2. Prelreatm ent o f  rats with the anti-C R H
induced a small,
in plasma B levels compared with NRI 
p r e t r e a tm e n t .  Continuous infusion o f 4.0 i^g IL -lß /day  
in d u c e d  a significant increase in plasma ACTH and B 
levels c o m p a re d  with infusion o f saline. The IL-lß-in- 
d u c e d  increase  in plasma A CTH levels was significantly 
r e d u c e d  by pretreatm ent o f the rats with anti-CRH
a n t i s e r u m  {P < whereas the IL-Iß-i
p la s m a  B response was slightly, but not significantly 
d im in is h e d .  The IL-1 ß-induced increase in total 
a d r e n a l  weight was not simiillcantlv decreased by
• W i W3
p r e t r e a tm e n t  o f  the rats with the anti-C RH  antibody 
(55.3 4- 5.4 nm vs 5 2 .7 +  4.4 ma, N R I/IL - lß  vs anti-
\  mm  ■ n » ^  I
C R F I / I L - l ß ,  NS). Rectal tem perature was significantly 
in c r e a s e d  by IL -Iß  com pared with saline infusion 
(P <  0 .0 5 ) .  T reatm ent with anti-C R H  antiserum prior 
to s a l i n e  infusion had no signilieant elicci on rectal
'usion of 4.0 j.ig
r a tu r e  nor did treatment with anti-CRH anti­
s e ru n i  significantly affect (he 11,-I ß-induced increase in 
rec ta l  tem perature . Continuous 
I L - l ß / d a y  f°*' 3 days significantly decreased body 
w e ig h t  gain, and food and fluid intake compared with 
v a lu e s  in  saline-infused animals. Treatm ent of rats with 
a n t i - C R H  antiseruni prior to saline infusion had no 
eflect o n  these three parameters nor did it significantly 
a i l e d  t h e  11.-1 ß-induced decreases in body weight gain 
and  f o o d  intake. The IL -1 ß-induced decrease in fluid 
in ta k e ,  however, was significantly larger in the group 
o f  a n im a l s  pretrcated w anti-C R H  antiseruni 
c o m p a r e d  with that o f animals pretrcated with NRI
(P 0.05).
e c ts  o f  macn depletion or 
•sectomv (HPX) in rats infused i.p . with
or :
m e n t
T h e  effects of macrophage depletion by pretreat
osomes containing di
«ri
o f rats vv dm
osphonate (C bM D P) on the
e a r l i e r  m entioned parameters in rats infused i.p. with 
I L - l ß  (4.0 jig day) or saline are shown in 1 ‘inure 3.
P r e t r e a tm e n t  of rats with ChM D IM iposom es had no 
s ig n if ic a n t  eflect on plasma A CTH  ami B levels and on 
to ta l  a d re n a l  weight compared with values of contro
a vra ts .  C o n tin u o u s  i.p. infusion o f 4.0 jig IL-1
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induced a significant increase in plasma A C T H  and B 
levels com pared with saline infusion. P retreatm ent of 
rats with C LM D P-liposom es significantly raised the 
IL-1 ß-induced increase in p lasm a A C T H  and B levels 
(both P <  0.05). P re treatm ent o f  the rats with 
C hM D P-liposom es induced a slight, a lthough no t 
significant, increase in the IL-1 ß-induced increase in
total adrenal weight (55.8 ±  1.3 mg vs 63.4 +  2.7 mg, 
saline/IL-1 ß vs C L M D P -liposom es/IL -lß , NS). IL - lß
infusion induced a increase in rectal
temperature. P re trea tm ent with Cl2M D P-liposom es 
slightly, though no t significantly, increased rectal 
tem perature o f  saline-infused rats, and  it had no
significant effect on the IL-1 ß-induced increase in rectal 
tem perature. C on tinuous infusion o f  4.0 jig IL -lß /day  
significantly decreased body  weight gain, and food and 
fluid in take as com pared  to  contro l values. T reatm ent 
o f  rats with C L M D P-liposom es prio r to saline infusion 
slightly, though  no t significantly, decreased these three 
param eters, and  it also did no t significantly affect the 
IL-1 ß-induced decrease in body weight gain, food and 
fluid intake.
All o f  the H P X  ra ts  infused with 0.5 (.ig IL - lß /  
day  had died within 18 h after pum p im plantation, 
whereas sham -opera ted  rats did not die during IL - lß  
infusion.
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Figure I. Effects of 3 days continuous intracerebroventricular (i.c.v.) infusion of rats.
With saline ( • )  or increasing doses of recombinant human IL-lß [100 ng/day (A )  or 500 ng/day (■ ) ]  on plasma ACTH (A) 
and B (B) levels, on rectal temperature (C), body weight change (D), and on food (E) and fluid (F) intake. The i.c.v. cannula 
was implanted stereotaclically 10 11 days before implantation o f  the osmotic minipumps. Subcutaneous implantation of the 
pumps and subsequent connection to the i.c.v. cannula was performed between 1430 1630 on day 0 (arrow). Data are expressed 
as means ±  SEM of 10 14 rats. Inset: corrected areas under the curves (AUC) for days 1 3 o f  i.c.v. infusion o f saline (□ ) ,
100 ng IL-1 p ( w)  or 500 ng IL-lß/day (■ ) .  ACTH levels o f  rats infused with 100 ng IL-lß/day are missing due to plasma 
shortage, * P <  0.05 vs saline.
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Figure 2. Effects of 3 days chronic intraperitoncal (i.p.) infusion of saline or 4.0 fig IL-lß/day following pretreatment of rats.
With an anti-CRH antiseruni or normal rat IgG [NRI/suline (O ), N R I/IL -lß  ( # ) ,  anti-CRH/saline (□ ) ,  anti-CRH/IL-lß (■ )]
on plasma ACTH (A) and B (B) levels, on rectal temperature (C), body weight change (D), and on food (E) and fluid (F) intake. 
The anti-CRH antiseruni and NRI ( 100 nmol/rat) were injected intravenously via the jugular cannula on day 0, 2.5-3 h before 
i.p. implantation o f  the osm otic minipumps (arrow). Each point represents the mean ±  SEM of eight rats.
>C 1
>  t % *
Effects o f  dexamethasone or adre nah 
{ADX) in rats infused i.p. with IL~I/i or saline
Figure 4 shows the effects o f treatm ent o f rats with
param eters in
rats infused with IL - lß  (2.0 j.ig/day) or saline. Daily 
treatm ent o f  rats with dexam ethasone 
abolished the effects o f  IL-1 [3 on plasm a A C T H  and B 
levels (A C TH : P  <  0.001, B: P  <  0.0005) and on total 
adrenal weight (57.5 ±  1.5 mg vs 25.1 ±  0.6 mg, sí 
IL - lß  vs DEX/IL-1 ß, P <  0.0005). The IL -lß-i 
decrease in Ic intake
P  <  0.01,
by daily
: P 0.05).
All o f  the A D X  rats infused with 0.5
had died within 18 h i an ta  lion,
none of the sham-operated rats died 
infusion.
Iß
DISCUSSION
The present study shows that continuous i.c.v. 
infusion o f low doses of IL-lß  in rats stimulates the 
activity o f  the HPA axis, increases rectal temperature 
and  decreases food and fluid intake. The results are 
complementary to those in other recent studies, 
showing th a t  continuous i.c.v. infusion of IL-lß, in 
doses as used in this study, decreases the activity of the
hypothalamus-pituitary-gonadal axis15-16 and decreases
thyrotropin-releasing hormone gene expression.17 It is
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of interest that the doses o f  IL - lß  which were effective 
in the present study (100 and 500 ng IL -lß /day , i.c.v.) 
were considerably lower th an  the dose o f IL - lß  which 
was needed for stim ulation o f  the p itu itary-adrenal axis 
in the previous study (2000 ng IL-1 ß/day), in which the 
cytokine was given by continuous i.p. infusion.6 These 
observations suggest tha t the site o f  action o f IL - lß  
during chronic i.c.v. infusion is located in the central 
nervous system.
Pretreatm ent o f  animals with the an ti-C R H
antibody reduced the p lasm a A C T H
response to IL - lß  infusion, indicating tha t the C R H  
system plays an interm ediate role in the stim ulation o f  
the HPA axis by chronic i.p. IL - lß  adm inistration. This 
agrees with da ta  o f o ther researchers who did
dem onstra te  such a role for C R H  in the IL-1 ß-induced 
stim ulation o f  the H PA  axis in short-term  
im ents.18 211 It has to  be noted , however, that the plasm a 
A C T H  response to  chronic IL - lß  adm inistration was 
no t completely abolished by pre trea tm ent with the 
an ti-C R H  antiserum . There are  a  num ber o f  possible 
explanations for this observation. First, it m ay be th a t  
the am o u n t o f  the an ti-C R H  an tibody  we used was 
insufficient to fully neutralize all o f  the secreted C R H . 
Second, factors structurally  distinct from  C R H  m ight 
be involved in the activation o f  the H PA  axis by 
chronic IL - lß  infusion. C hronic  stress has been show n 
to increase vasopressin im m unoreactiv ity  in C R H  axon
terminals in the external zone o f median
eminence21'" and  acute adm in is tra tion  of IL - lß  in vivo
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Figure 3. Effects of continuous intraperitoneal (i.p.) administration of saline or 4.0 fig IL-lß/day for 3 days in rats which were 
treated with saline or with liposomes containing ChM DP, to induce depletion of macrophages |saline/salinc (O X  saline/IL-lß ( • ) ,  
ChMDP-liposomes/saline ( □ ) ,  ChMDP-liposomes/IL-lß ■ » ,  on plasma ACTH (A) and B (B) levels, on rectal temperature (C), 
body weight change (D), and on food (E) and fluid (F) intake.
C bM D P-Iiposom e suspension or saline was administered intravenously (0.8 ml via the tail vein) and intraperitoneally (0.2 ml) 
twice (between 0900-1000 and between 1130-1230), 2 days prior to i.p, implantation o f  the osm otic m inipum ps (day 0, arrow). 
D ata are expressed as means ±  SEM  o f 5 8 rats.
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Figure 4. Effects of chronic intraperitoneal (i.p.) infusion.
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2.0 |.ig IL -lß /day  in rats receiving saline or dexamethasone [SALINE/IL-1 ß (O ) . D E X /IL -lß  ( # ) ]  on plasma ACTH  (A) and 
Infusion o f  B (B) levels, on recial temperature (C), body weight change (D), and on food (E) and Huid (F) intake. Satine or 
dexamethasone (600 ng/injeetion/rat) was administered subcuUmeously twice a day (between 1300-1430 and between
2230 2330) from day — I up to and including day 2. The osmotic minipumps were implanted on day 0 (arrow). Each point 
represents the mean ±  SEM o f  7 -8 rats.
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C l:M D P-contain ing liposomes the p lasm a A C T H  and 
B response to subpyrogenic doses o f  endotoxin  was 
completely prevented. T rea tm en t with C bM D P -con- 
taining liposomes eliminates m acrophages as the 
C hM D P-conta in ing  liposomes are selectively ingested 
by macrophages resulting in the death  o f  the
13macrophages by the toxic eflect o f  CI2M D P.
Surprisingly, the effect o f  IL - lß  011 the activity o f  
the HPA axis was significantly enhanced instead o f  
decreased in m acrophage-depleted rats com pared  with 
control rats. It is know n that m acrophages can also 
produce cytokines which inhibit the H PA  axis, such as 
interferon-y,u or which can antagonize IL - lß  activity, 
such as IL-Iß  receptor an tag o n is t .1,1 It is speculated that 
decreased production  o f these peptides accounts for the 
observed enhancement o f  the stim ulation o f  the HPA 
axis by IL-1 ß in m acrophage-depleted rats in our study. 
In contrast with the additive effect on IL-1 ß-induced 
activation o f the H PA  axis, m acrophage depletion had 
no eflect on the increase in rectal tem perature  and on 
the anorexia induced by IL -lß , implying that 
macrophage-derived products  are probably  no t in 
volved in these effects. A similar discrepancy was 
observed in the study using the an ti-C R H  antiserum: 
iinm unoneutralization o f  C R H  decreased the IL -lß -in - 
duced activation o f  the H P A  axis whereas it did not 
significantly alter the effect o f  i.p. infused IL - lß  on 
rectal tem perature and food intake.
The authors investigated w hether high or low 
concentrations o f  circulating glucocorticoids are 
capable of m odulating  the effects induced by chronic 
i.p. IL -lß  infusion. The present study shows tha t 
continuous IL - lß  infusion, in a dose as low as 
0.5 j.ig/day, in adrenalectomized rats was lethal within 
18 h. This observation suggests tha t an intact function 
o f  the adrenal glands is needed to survive the stress 
induced by IL - lß  infusion. The
that daily adm inistra tion  
dexamethasone completely abolished the activation o f  
the H PA  axis by i.p. infusion o f  2.0 f.ig IL -lß /day . This 
observation fits well in the concept o f  im m unoregula- 
tory feedback between IL - lß  and glucocorticoid
p ro ­
file
a harmful overshoot o f defense reac-
hormones, in which glucocorticoids block 
duction and action o f  IL - lß  
animal 
tions.3-15
Infection and an im ation  are often ac­
com panied by a sustained activation o f  the H P A  axis 
and  by fever and  anorexia. There  is compelling 
evidence that IL - lß  is an im p o rtan t  trigger for the 
activation of the H P A  axis under these conditions. This 
study dem onstrates tha t lower doses o f  IL - lß  were able 
to activate the H PA  axis when infused i.c.v. com pared
Furtherm ore, the present study provides
that the C R H is involved in the
o f  IL - lß .  However, o ther  m ediators  structurally 
distinct from  C R H , such as vasopressin, might also be 
involved. This study provides no  evidence for a direct
stim ulatory  effect o f  IL - lß  on  the release oí 
corticosterone by the adrenal gland which is o f  
sufficient m agnitude to resist the stress o f chronic i.p. 
IL -lß -adm in is tra tion . It seems tha t endogenous 
m acrophage-derived m ediators, induced by i.p. IL - lß  
adm inistration , express an  inhibitory rather than  a 
stim ulatory  effect on the activity o f the H PA  axis. 
Finally, exogenous adm in is tra tion  o f  glucocorticos- 
teroids blocks the effect o f  IL - lß  on the HPA axis. 
Thus, bo th  m acrophage-derived  products as well as 
glucocorticoids exert an inhibitory effect on 
IL-1 ß-induced activation  o f  the H P A  axis, thereby 
preventing excessive stim ulation  o f  this axis by IL - lß ,  
which would result in a dangerous state of suppression 
o f the im m une system.
MATERIALS AND M ETH O DS
M aterials
Recombinant human interleukin-lß (IL-lß) was ob­
tained from Glaxo (Glaxo I MB, Geneva, Switzerland). The 
IL-lß preparation used in experiments 2, 4, and 5 (batch 
RNB 18511/ 14-B) has a specific activity of 2.5 x 107U/mg 
protein and the IL-lß preparation used in experiments 1, 3 
and 6 (batch RNB 00488/14) has a specific activity of 
1.2 x 107U/mg protein. According to the specifications of 
the supplier, endotoxin contamination was negligible 
(<1 .2  ng/mg protein as detected in the limulus amoebocyte 
lysate assay).
Dexamethasone was obtained from Organon (Oss, The 
Netherlands). IL-lß was diluted to the desired concentration 
in pyrogen-free saline just before use. All chemicals used were 
of analytical grade.
A nimals
Male Wistar rats (Cpb:WU, 10-12 weeks old, weight 
210-230 g in experiments 2-6 and 260-280 g in experiment 1 ) 
were obtained from the local breeding facility. The animals 
were individually housed in Plexiglass cages in an artificially 
lighted room (lights on at 0700 h; lights oil’ at 1900 h). Rats 
were provided commercial rat chow (RMH-TM, Hope 
Farms, Woerden, The Netherlands) and tap water ad libitum. 
Hypophysectomized and sham-hypophysectomized rats (ex­
periment 3) were provided with 5% glucose in their drinking 
solution whereas adrenalectomized and sham-adrenalcctom- 
ized rats (experiment 6) were provided wiUi a 0.9% NaCl 
drinking solution.
Experim en ta l pro ce dur es
To diminish the stress by the experimental procedures
the animals were handled daily by experimentator.
activation o f the H PA  axis by continuous i.p. infusion
starting 1 week before cannulation. Blood was collected from 
conscious, freely moving rats by means of a chronic jugular 
cannula. Rats were cannulated according to the method 
described by Steffens7 with some modifications as described 
earlier.1 For continuous intracerebroventricular (i.c.v.)
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infusion of IL-lß, a stainless steel cannula (Brain Infusion
Kit, Corp., Palo Alto, CA) was stereotactically
implanted in the right cerebral ventricle of the brain 
immediately following jugular cannulation (coordinates 
according to the Paxinos and Watson atlas:9 8.2 mm anterior 
from the interaural line; 1.4 mm lateral to the antero-pos- 
terior suture; 4.5 mm ventral from the surface of the skull). 
Adrenalectomy (ADX) or sham-ADX was performed using 
the dorsal approach under halothane (ICI Pharmaceuticals, 
Macclesfield, UK^Oa-NaO anaesthesia between 0930-1130,
4 days after cannulation of the jugular vein. Hypophysec- 
tomy (HPX) or sham-HPX was done by the parapharyngeal 
approach"1 immediately prior to cannulation of the jugular
vein.
Four to eleven days after jugular vein cannulation rats 
were equipped with osmotic minipumps (1.0 j.tl/h for 3 days,
Experim ent 4
In this experiment the effects of continuous i.p. infusion of 
saline or 4.0 j.ig IL-lß/day were studied in macrophage- 
depleted or control rats. Depletion of splenic, liver and 
peritoneal macrophages11,14 was achieved by injecting rats 
twice [between 0900-1000 (i.v. and i.p.) and 1130 -1230 (i.v. 
and i.p.)] with liposomes encapsulating dichloromethylene 
diphosphonate (CUMDP) 2 days prior to implantation of the 
minipumps (day 0). 0.8 ml of a suspension of CliMDP-eon- 
taining liposomes was injected i.v. via the tail vein and 0.2 ml 
of this suspension was injected i.p. Control rats received 
injections with saline. In this experiment minipumps were 
implanted 7 8 days after jugular cannulation. There were 
four groups: saline/saline, saline/1 L-lß, CbMDP-liposomes/ 
saline and ChMDP-liposomes/IL-lß.
model 1003D, Al?.et Corp., Palo Alto, CA), which were 
loaded with either pyrogen-free saline or saline containing 
IL-lß. After loading, the pumps were equilibrated, immersed 
in saline at 37 'C for 3-4 h according to the instructions of the 
manufacturer. The pumps were implanted intraperitoneally 
(i.p.) under hal0thane-Or-N2O anaesthesia between 1430 and 
1630 (experiments 2-6). In experiment 1 the osmotic 
minipumps were implanted subcutaneously in the neck and 
connected to the i.c.v. cannula via a polyethylene tube which 
was also filled with saline or IL-Iß solution.
5
The effects of continuous i.p. infusion of 2.0 (.ig IL-lß/day in
rats with dexamethasone or saline were
investigated. Rats were injected subcutaneously twice a day 
for 4 days (day — 1 up to and including day 2) with 
dexamethasone (600 j.ig/0.5 ml) or saline (0.5 ml) between 
1300-1430 and 2230-2330. The osmotic minipumps were 
implanted 7-8 days after jugular cannulation (day 0). There 
were two groups: saline/IL-lß and dexamethasone/IL-lß.
Protocols
Experimen t 1
In this experiment we studied the effects of continuous i.c.v. 
infusion of saline or IL-lß. The osmotic minipumps were 
implanted 10-11 days after jugular cannulation and 
implantation of the i.c.v. cannula. Localization of the i.c.v. 
cannula was checked at the end of the experiment according 
to the method of Brakkee et al." There were three groups:
Experim ent 6
In this experiment the effects of continuous i.p. infusion of 
0.5 |.ig IL-1 ß/day were examined in ADX or sham-ADX rats. 
(Sham-)ADX was performed 4 days prior to implantation of 
the minipumps (day 0), which were implanted 7 8 days after 
jugular cannulation, At the end of the experiment rats were 
decapitated and it was checked macroscopically whether both 
adrenal glands were completely removed. There were two 
groups; sham-ADX/IL-l ß and ADX/IL-Iß.
saline, 0.1 (.igIL-1 ß/day and 0.5 (.ig IL-lß/day.
In all experiments rectal temperature was measured
Experiment 2
twice a day between 0815-0915 and between 1230 1430 in 
conscious hand-held rats by insertion of a thermal probe into
In this experiment il was studied whether pretreatment of rats 
with a monoclonal antibody directed against rat CRH (PFU 
83, batch 9102-A)12 or normal rat IgG (NRI) modulated the
s of continuous i.p. of saline or 4.0 \.ig
IL-lß/day. The anti-CRH antibody or NRI were injected 
intravenously (i.v.) in a volume of 1.0 ml/rat ( 100 nmol/ml) 
2.5 3 h prior to implantation of the minipumps (day 0), 7 
days after jugular cannulation. There were four groups: 
NRI/saline, NRI/IL-1 ß, anti-CRH/saline and anti-CRH/1 L- 
lß.
the rectum. The mean daily rectal temperature for each rat 
was determined by averaging the morning and afternoon 
rectal temperatures. Body weight was measured daily at 
about the same time (0815-0915) and daily body weight 
change was calculated by subtracting the values measured on 
subsequent days. Food and water intake was estimated daily 
between 0815 and 0900 by weighing the residual food pellets 
and water for individual cages. At the end of the experiments 
1 5 (day 3) rats were killed by decapitation, 
removed, freed of fat and weighed. Total adrenal weight is 
expressed as the summed weight of both adrenals,
Experiment 3
In this experiment the effects of continuous i.p. infusion of 
0.5 j.ig IL-lß/day were examined in HPX or sham-HPX rats. 
(Sham-)HPX was performed immediately before jugular 
cannulation, 4 days prior to implantation of the minipumps 
(day 0). At the end of the experiment rats were decapitated 
and it was checked macroscopically whether the pituitary 
gland was completely removed. There were two 
sham-HPX/IL-1 and HPX/IL-1.
In all experiments, was collected once a day
(between 1000 and 1200) from freely moving rats for 5 days, 
starting 1 day before implantation of the minipumps (day — 1 
up to and including day 3). Blood samples (1.8 ml) for 
measurement of plasma ACTH and B levels, were collected 
on ice in tubes containing EDTA [45 (.d of a 10% (W/V) 
solution in saline]. The samples were gently shaken and spun 
for 10 min at 1500 x g  (4"C). Plasma was separated and red 
blood cells resuspended in sterile physiological saline (1,3 ml) 
and returned to each rat. Plasma samples were stored at
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— 20 C in aliquots of 250 (.il to which 60 KIE aprotinine 
(Bayer AG, Leverkusen, Germany) was added.
Hovmone me asur einen ts
Plasma ACTH and B values were measured by 
radioimmunoassay as described by Sweep et al!'
Statistical analysis
In the statistical analysis first the areas under the curves 
(AUC) were calculated. These were corrected for pretreat­
ment values by subtracting the pretreatment value on day 0 
from the treatment values on each day (day I 3). Data of 
experiment 1 were analysed for a dose- response relationship 
by using a one-way analysis of variance (ANOVA) of the 
AUC and the dose of IL-lß. When a significant 
dose response relationship was found, Dunnett’s /-test was 
performed in order to determine which dose of IL-lß induced 
a significant effect compared with the effect of saline infusion. 
In the experiments 2 and 4 the AUCs were analysed by 
Dunnett’s /-test to determine whether pretreatment of rats 
with anti-CRH antiserum or ChMDP-liposomes significantly
basal or IL-lß stimulated plasma ACTH and B 
levels. Data of experiment 5 (AUCs) were also analysed by 
Dunnett’s /-test. Differences are considered to be significant
if P < 0.05.
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